General Information
Version
1.27
Revision date
2025-04-14
Product name
Golimumab Formulation
1.2.1 Relevant identified uses
Pharmaceutical
Icons in SDS
Company Information
company name
MSD
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@msd.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture Respiratory sensitisation Category 1
Signal word
Danger
Hazard statements
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Prevention
P261 Avoid breathing mist or vapours. P284 Wear respiratory protection.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Respiratory sensitisation : Category 1
